Robot Based Gait Training Therapy for Pediatric Population With Cerebral Palsy Using the CPWalker
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03937700|
Recruitment Status : Recruiting
First Posted : May 6, 2019
Last Update Posted : May 6, 2019
|Condition or disease||Intervention/treatment||Phase|
|Cerebral Palsy||Device: CPWalker Robotic Exoskeleton||Not Applicable|
- To determine the use of the CPWalker rehabilitation platform, a robotic device composed by an exoskeleton linked to a walker that provides support and balance, as a gait training intervention in the pediatric cerebral palsy population.
- To create and define detailed guidelines consisting of robotic based treatment methods for gait rehabilitation.
- CPWalker can be used as a gait training intervention for pediatric patients with gait impairments due to cerebral palsy
- Performing lower limb training in conjunction with active head and trunk control therapies will improve functional gait levels
- Following 16-24 CPWalker training sessions, persons with cerebral palsy will show improvements in functional mobility when comparing pre-training measurements to post-training measurements
Participants will engage in an 8-week training program, consisting of 2-3 sessions per week based on the level of gait impairment. Percentage range of motion (ROM), partial body weight support (PWBS), and gait velocity are the principal parameters under variation during training.
Additionally, screening, baseline and post-training testing sessions will be conducted
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||30 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Robot Based Gait Training Therapy for Pediatric Population With Cerebral Palsy Using the CPWalker|
|Estimated Study Start Date :||June 1, 2019|
|Estimated Primary Completion Date :||June 1, 2024|
|Estimated Study Completion Date :||June 1, 2024|
Experimental: CPWalker Robotic-Assisted Gait Training
Each subject will participate in 16-24 gait training sessions in the CPWalker over the course of 8 weeks with each session lasting up to 2 hours
Device: CPWalker Robotic Exoskeleton
The CPWalker rehabilitation platform is a robotic device composed by an exoskeleton linked to a walker that provides support and balance to a child during overground training. The device is able to implement user's partial body weight support (PBWS) and allows the adaptation of exercises to the patient's capabilities by means of individual controllers for each joint, which increases the modularity of the system. Each joint of the CPWalker can operate in a range of modes with varied levels of robotic assistance or resistance
- 10-Meter Walk Test [ Time Frame: Change from baseline gait speed at 8 weeks ]This test will examine the patient's gait speed. Patients will be directed to walk at their preferred and maximum but safe speed. Patients will be positioned 1 meter before the start line and instructed to walk the entire 10-meter distance and past the end line approximately 1 meter. The distance before and after the course are meant to minimize the effect of acceleration and deceleration. Time will be recorded using a stopwatch and recorded to the one hundredth of a second.
- 6-Minute Walk Test [ Time Frame: Change from baseline distance ambulated at 8 weeks ]This test measures the distance a subject can walk indoors on a flat, hard surface in a period of 6 minutes, using assistive devices, as necessary. The test is a reliable and valid evaluation of functional exercise capacity and is used as a sub-maximal test of aerobic capacity and endurance. The test is patient self-paced and assesses the level of functional capacity. Patients are allowed to stop and rest during the test, however, the timer does not stop. If the patient is unable to complete the time, the time stopped is noted and reason for stopping prematurely is recorded. This test will be administered while wearing a mask to measure oxygen consumption.
- GAITRite Data Collection [ Time Frame: Change from baseline gait quality at 8 weeks ]The GAITRite system automates measuring temporal and spatial gait parameters via an electronic walkway connected to a computer. The GAITRite electronic walkway contains sensor pads encapsulated in a carpet to collect gait information. The system can be laid over any flat surface. The GAITRite electronic walkway for the study shall be a minimum of 14 feet long. The GAITRite data capture was chosen as measurement of the patient's overall gait quality. Patients will be asked to walk at a self-selected speed across the GAITRite electronic walkway with at least a two meter "flying start" to compensate for initial acceleration.
- Pediatric Balance Scale [ Time Frame: Change from baseline balance score at 8 weeks ]This test is a 14-item objective measure designed to assess static balance in pediatric populations. The functional activities that are assessed include sitting and standing balance during transfers, altered base of support, reaching, turning, eyes open and closed. Each item is scored from 0 to 4 points. The maximum score is 56 points.
- Selective Control Assessment of Lower Extremity (SCALE) [ Time Frame: Change from baseline selective voluntary motor control at 8 weeks ]This clinical tool quantifies selective voluntary motor control of the lower extremities in patients with cerebral palsy.
- Gross Motor Function Measure (GMFM-88) dimensions D (standing) and E (walking) [ Time Frame: Change from baseline gross motor function at 8 weeks ]This test measures the change in gross motor function with intervention in children with cerebral palsy
- Child and Adolescent Scale of Participation [ Time Frame: Change in children's baseline participation in activities at 8 weeks ]This questionnaire measures the extent to which children participate in home, school, and community activities as reported by family caregivers.
- Gillette Functional Assessment Questionnaire (FAQ) [ Time Frame: Change in baseline report of ambulatory function at 8 weeks ]This is a proxy-report measure that includes a ten-level classification of ambulatory function and 22 functional locomotor activities
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03937700
|Contact: Sara Prokup, DPTfirstname.lastname@example.org|
|Contact: Matt McGuire, DPTemail@example.com|
|United States, Illinois|
|Shirley Ryan AbilityLab||Recruiting|
|Chicago, Illinois, United States, 60611|
|Contact: Sara Prokup, DPT 312-238-1355 firstname.lastname@example.org|
|Contact: Matt McGuire, DPT 312-238-3457 email@example.com|
|Principal Investigator:||Arun Jayaraman, PT, PhD||Shirley Ryan AbilityLab|